[
  {
    "ts": null,
    "headline": "Danaher Insiders Sold US$250m Of Shares Suggesting Hesitancy",
    "summary": "The fact that multiple Danaher Corporation ( NYSE:DHR ) insiders offloaded a considerable amount of shares over the...",
    "url": "https://finnhub.io/api/news?id=9cbd1a2e63ff0d8f498f7f7be62d3216e964f3d33341eacd34687bc83bb75327",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754398810,
      "headline": "Danaher Insiders Sold US$250m Of Shares Suggesting Hesitancy",
      "id": 136212441,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "The fact that multiple Danaher Corporation ( NYSE:DHR ) insiders offloaded a considerable amount of shares over the...",
      "url": "https://finnhub.io/api/news?id=9cbd1a2e63ff0d8f498f7f7be62d3216e964f3d33341eacd34687bc83bb75327"
    }
  },
  {
    "ts": null,
    "headline": "Bio-Techne: Coveted Life Sciences Asset On Sale Due To Academic Pressures",
    "summary": "Headwaters Capital sees deep value in Bio-Techne as academic cuts weigh on shares. Learn why this life sciences leader could rebound in 2027âread the thesis.",
    "url": "https://finnhub.io/api/news?id=c0f8643ff6a9b2b5a2471056042b67ba3b521f1def3d5eb2f936fdb1bee4ce1a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754390700,
      "headline": "Bio-Techne: Coveted Life Sciences Asset On Sale Due To Academic Pressures",
      "id": 136213726,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1168939901/image_1168939901.jpg?io=getty-c-w1536",
      "related": "DHR",
      "source": "SeekingAlpha",
      "summary": "Headwaters Capital sees deep value in Bio-Techne as academic cuts weigh on shares. Learn why this life sciences leader could rebound in 2027âread the thesis.",
      "url": "https://finnhub.io/api/news?id=c0f8643ff6a9b2b5a2471056042b67ba3b521f1def3d5eb2f936fdb1bee4ce1a"
    }
  },
  {
    "ts": null,
    "headline": "Janus Henderson Forty Fund Q2 2025 Commentary",
    "summary": "Janus Henderson Forty Fund returned 19.34% and the Russell 1000Â® Growth Index returned 17.84%. Read more here.",
    "url": "https://finnhub.io/api/news?id=e8cde222c733fdc689f8555bef178ea0fd9b78d08b4e25052ccab6bc4bf52240",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754359800,
      "headline": "Janus Henderson Forty Fund Q2 2025 Commentary",
      "id": 136205380,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1478156131/image_1478156131.jpg?io=getty-c-w1536",
      "related": "DHR",
      "source": "SeekingAlpha",
      "summary": "Janus Henderson Forty Fund returned 19.34% and the Russell 1000Â® Growth Index returned 17.84%. Read more here.",
      "url": "https://finnhub.io/api/news?id=e8cde222c733fdc689f8555bef178ea0fd9b78d08b4e25052ccab6bc4bf52240"
    }
  }
]